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Abstract
Background: It is of growing interest to develop novel approaches to initiate differentiation of mesenchymal stem cells
(MSCs) into cardiomyocytes. The purpose of this investigation was to determine if Sphingosine-1-phosphate (S1P), a
native circulating bioactive lipid metabolite, plays a role in differentiation of human umbilical cord mesenchymal stem
cells (HUMSCs) into cardiomyocytes. We also developed an engineered cell sheet from these HUMSCs derived
cardiomyocytes by using a temperature-responsive polymer, poly(N-isopropylacrylamide) (PIPAAm) cell sheet technology.
Methods: Cardiomyogenic differentiation of HUMSCs was performed by culturing these cells with either
designated cardiomyocytes conditioned medium (CMCM) alone, or with 1 μM S1P; or DMEM with 10% FBS + 1 μM
S1P. Cardiomyogenic differentiation was determined by immunocytochemical analysis of expression of
cardiomyocyte markers and patch clamping recording of the action potential.
Results: A cardiomyocyte-like morphology and the expression of a-actinin and myosin heavy chain (MHC) proteins
can be observed in both CMCM culturing or CMCM+S1P culturing groups after 5 days’ culturing, however, only the
cells in CMCM+S1P culture condition present cardiomyocyte-like action potential and voltage gated currents.
A new approach was used to form PIPAAm based temperature-responsive culture surfaces and this successfully
produced cell sheets from HUMSCs derived cardiomyocytes.
Conclusions: This study for the first time demonstrates that S1P potentiates differentiation of HUMSCs towards
functional cardiomyocytes under the designated culture conditions. Our engineered cell sheets may provide a
potential for clinically applicable myocardial tissues should promote cardiac tissue engineering research.
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Background
Mesenchymal Stem cells (MSCs) are pluripotent cells that
are able to differentiate into various specific cell types.
Because of their plasticity, MSCs have been suggested as
potential therapies for numerous diseases and conditions.
In vitro differentiation of MSCs into cardiomyocytes offers
a new cellular therapy for heart diseases. Therefore, it is
of growing interest to develop novel approaches to initiate
differentiation of various types of MSCs into cardiomyo-
cytes. Human umbilical cord (UC) has been a tissue of
increasing interest for such purpose due to the MSCs
potency of stromal cells isolated from the human UC
mesenchymal tissue, namely, Wharton’s jelly[1]. A number
of recent studies have shown that HUMSCs are able to
differentiate towards multiple lineages including neuronal
and myocardiogenic cells in vitro, thus providing a great
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However, differentiation of MSCs into specific cell
types is a complex biologic process involving a sequence
of events and cellular signalling pathways that are still
poorly understood. To understand the cellular signalling
for differentiation of MSCs has been one of the research
focuses in MSCs research. Sphingosine-1-phosphate
(S1P), a key member of Sphingolipids, is a circulating
bioactive lipid metabolite that has been known for many
years to induce cellular responses, including proliferation,
migration, contraction, and intracellular calcium mobili-
zation. Recent Evidence indicated that S1P can function
as an intracellular second messenger implicating them in
physiological processes such as vasculogenesis. Interest-
ingly, recent evidence has also demonstrated that S1P has
potent effects on the embryonic and neural stem cell
biology such as differentiation, proliferation and mainte-
nance[4-6]. Based on these results, we speculate that S1P
could have a potential to affect biology of MSCs derived
cardiomyocytes. Thus, the aims of the present study are
two folds; firstly, to determine whether S1P can promote
differentiation of HUMSCs towards functional matured
cardiomyocytes under the designated culture conditions;
secondly, to develop an engineered cell sheet from
HUMSCs derived cardiomyocyte with potential clinical
application by using temperature-responsive polymer,




Human cardiac myocytes (HCM, Cat. No. 6200) were pur-
chased from ScienCell Research Laboratories (San Diego,
CA, USA). The cells were initially expanded in 75 cm2
flasks (NUCN, Cat. No.156499) pre-coated with poly-L-
lysine (2 μg/cm2) by using culturing medium consisting of
500 ml of basal medium, 25 ml of fetal bovine serum
(ScienCell Research Laboratories, Cat. No. 0025), 5 ml of
cardiac myocyte growth supplement (Cat. No.6252) and
5 ml of penicillin/streptomycin solution (Cat. No.0503).
All cells were maintained at 37°C in humidified air with
5% CO2. Cellular growth was monitored every day by
inspection using phase-contrast microscopy. The medium
was changed every other day. The cells were sub-cultured
when they were over 90% confluence.
HUMSCs were also purchased from ScienCell Research
Laboratories (San Diego, CA, USA). The cells were also
initially expanded in 75 cm2 flasks (NUCN, Cat.
No.156499) precoated with poly-L-lysine (2 μg/cm2) with
culturing medium consisting of 500 ml of basal medium,
25 ml of fetal bovine serum (ScienCell Research Labora-
tories, Cat. No. 0025), 5 ml of mesenchymal stem cell
growth supplement (Cat. No.7552) and 5 ml of penicillin/
streptomycin solution (Cat. No.0503). All cells were main-
tained at 37°C in humidified air with 5%CO2. Cellular
growth was monitored every day by phase-contrast
microscopy.
Preparation of cardiac myocyte condition medium
The cardiac myocytes conditioned medium (CMCM) was
prepared in T-75 flasks by culturing cardiomyocytes in
DMEM (D 6429 Sigma-Aldrich, St. Louis, MO) and 10%
FBS. When the cardiac myocytes were over 50% conflu-
ence, the medium was then collected and centrifuged at
approximately 800 g for 10 minutes at room temperature,
and the supernatant was filtered for use as conditioned
medium.
Cardiac Differentiation
After 5-8 passages, HUMSCs were plated on poly-L-
lysine coated coverslips in 24-well plates at the density of
1 × 103 cells/cm2 in DMEM +10%FBS and grown to
adherence. They were then cultured in different condi-
tional mediums including cardiac myocytes condition
medium (CMCM) plus 1 μM S1P or cardiac myocytes
condition medium or DMEM +10% FBS plus 1 μM S1P.
The medium was changed every 3 days. Cardiac differen-
tiation of HUMSCs was assessed at different time points
by morphology and immunostaining with cardiac myo-
cyte specific markers.
Immunocytochemistry
The medium was first removed and the cells were washed
twice with PBS, fixed for 30 min with 4% paraformalde-
hyde. Cells were permeabilized for 20 min with 0.1% Tri-
ton X-100 and then blocked for 30 min in 5% normal goat
serum. Cells were then incubated with the primary anti-
body (Ab) (either mouse anti-a-actinin (sarcomeric) at a
dilution of 1:200, or mouse anti-myosin cardiac heavy
chain a/b at a dilution of 1:4 (Millipore, Billerica, MA,
USA) in PBS-1% BSA overnight at 4°C. Excess primary
antibody was removed by a triple wash in PBS, and the
cells were then incubated with secondary Ab (Rhodamine-
conjugated anti-mouse IgG (Millipore, Billerica, MA,
USA), at dilutions of 1:100 in PBS at room temperature
for 1 h. After washing three times with PBS-1% FBS, the
coverslips were mounted onto glass slides in Vectashield
(Vector Laboratories, Burlingame, CA, USA). Examination
of the slides was performed using a confocal microscope
equipped with a digital camera. Negative control (omit pri-
mary antibody) was included in all immunofluorescent
staining. Immunolabelled cells were viewed using Zeiss
LSM 510 laser scanning confocal microscope (Zeiss Ltd,
Jena, Germany) equipped with argon and helium-neon
lasers, which allowed excitation at 550 nm wavelengths for
the detection of Rhodamine at 570 nm, respectively. All
images presented are single optical sections. Images were
saved and later processed using Zeiss LSM Image Bowser
(Zeiss Ltd).
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Electrophysiological measurement
Electrophysiological measurements were performed on
human UC-MSC-derived caridomyocytes in S1P+CMCM
and CMCM groups. According to the results of immunos-
taining, the cardiomyocyte-like cells were chosen at co-
culture time point of 10 days. For electrophysiological
recordings, the cells were grown on glass coverslips at the
density that enabled single cells to be identified. Whole-
cell currents were recorded using the patchclamp techni-
que, a 200B amplifier (Axon Instruments, Foster City, CA,
USA), and with patch pipettes fabricated from borosilicate
glass capillaries (1.5 mm outer diameter; Fisher Scientific,
Pittsburgh, PA, USA). The pipettes were pulled with a PP-
830 gravity puller (Narishige, Tokyo, Japan), and filled
with a pipette solution of the following composition (in
mmol/L): CsCl 130, NaCl 10, HEPES 10, EGTA 10, pH
7.2 (CsOH). Pipette resistance ranged from 2.0 to 3.0 MΩ
when the pipettes were filled with the internal solution.
The perfusion solution contained (in mmol/L): NaCl 140,
KCl 4, CaCl2 1.8, MgCl2 1.0, HEPES 10, and glucose 10,
pH 7.4 (NaOH). Series resistance errors were reduced by
approximately 70-80% with electronic compensation. Sig-
nals were acquired at 50 kHz (Digidata 1440A; Axon
Instruments) and analyzed with a PC running PCLAMP
10 software (Axon Instruments). All recordings were
made at room temperature (20-22°C).
Synthesis of thermo-responsive copolymer, film coating
and characterization
Chemicals
N-isopropylacrylamide (NIPAAm, 98% pure) was pur-
chased from Sigma-Aldrich and was freshly recrystal-
lized in hexane, followed by freeze-drying before use.
Hydroxypropyl methacrylate (HPM) and 3-trimethoxysi-
lylpropyl methacrylate (TMSPM, the cross-linking
agent) were purchased from Aldrich and used as sup-
plied. The initiator 2, 2-azobisisobutyronitrile (AIBN)
was purchased from BDH (UK) and was fully recrystal-
lised in ethanol followed by freeze-drying before use.
The solvents including ethanol, acetone and n-hexane
were all above 99% pure (Aldrich) and used as supplied.
Water used was processed using Elgastat ultrapure
(UHQ) system. The silicon wafers were purchased from
Compart Technology Ltd (UK) and were cut into 1 ×
1 cm2 cuts before use. They were cleaned by 5% (v/v)
Decon 90 solution (Decon Laboratories), followed by
rinsing with UHQ water and dried. The glass coverslips
with diameter of 13 mm were purchased from VWR
(Belgium). All plastic vessels (except those for single use
in cell culture) were cleaned by soaking them in 5%
Decon solution. All glassware was immersed into pir-
anha solution (H2O2: H2SO4 = 1:3 by volume) for
30 min, followed by abundantly rinsing with tap water
and UHQ water.
Synthesis of the Copolymer
Poly(N-isopropylacrylamide) copolymer (PNIPAAm) was
synthesized by free radical polymerization following the
procedures as reported with modifications[7-9]. Mono-
mers of NIPAAm (2 g), HPM (0.13 g) and TMSPM (0.22
g) were kept at the molar ratios of 1:0.05:0.05. These
samples together with 10 ml of absolute alcohol were
added into a three necked flask with a condenser, and
subsequently purged with nitrogen for about 10 min.
1 mol% of the total (NIPAAm + HPM + TMSPM) of
AIBN was added into the mixture solution (0.0319 g).
The mixture was then kept under heating and stirring at
60°C overnight under nitrogen protection. The solvent
ethanol was then evaporated and a small amount of acet-
one was then added into the remaining sample to dis-
solve it. The liquid was then added drop wise into
n-hexane for precipitation. The precipitation process
was repeated three times using acetone as solvent and n-
hexane as non-solvent. The product was then dried at
-60°C in the vacuum freeze dryer and stored in a refrig-
erator for use. Both FTIR and NMR studies confirmed
the structure and composition of the copolymer.
Film formation and characterization
The PNIPAAm copolymer was dissolved into absolute
ethanol at 1 or 2 mg/ml. The solution was then used to
form PNIPAAm copolymer films by spin coating using a
single wafer spin processor (Laurell Technologies, North
Wales) at 3000 rpm and the spin coating time of 20 s.
The coated films were dried in air for at least 30 min and
then annealed for 3 h at 125°C under vacuum to facilitate
3-trimethoxysilyl cross-linking and reacting with hydro-
xyl groups, and to remove the residual solvent. Any un-
reacted monomers and unconnected copolymers were
extracted by soaking and washing the wafers or coverslips
in ethanol and water thoroughly. The thickness of the
coated copolymer films was determined from films
coated onto optically flat silica wafer, thus facilitating
spectroscopic ellipsometry (Jobin-Yvon UVISEL, France).
Upon the use of refractive index of 1.47 for the copoly-
mer, the dry films were found to be between 3-5 nm. For
cell culturing, the copolymer films were coated onto glass
cover-slips suitable for placing into the wells of 24-well
cell culture plate and undertaking microscopic
observation.
Culturing and thermo-responsive detachment of cell
sheets
The glass coverslips coated with PNIPAAm copolymer
films were sterilized for 1 h by UV and then transferred
into 24 well tissue culture plates for subsequent use.
Some of the glass coverslips were half coated so that the
bare glass surfaces worked as control. Before starting cell
culture, the coverslips were rinsed repeatedly with PBS
and the cells were planted on the coverslips immersed in
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medium as described above, at the density of 1.0 ×
104 cells/well and cultured for 6-7 days at 37°C in humid
air with 5% CO2. Cell growth status and morphology was
observed by inverted phase contrast microscope
(TE2000-U, Nikon). The number of adhesive cells was
counting by hematocytometer. After aspiration of out-
spent medium, the cold fresh culture medium (less than
20°C) was introduced accompanied by gently pipetting.
The assessments focused on cell growth under culture
condition at 37°C and the extent of detachment at 20°C.
It was found that films coated at 1 and 2 mg/ml provided
healthy growth and swift detachment of cell sheets when
the 24-well plates were taken out of the 37°C incubator
and left for cooling at 20°C. Gentle scratching around the
edge of the glass coverslip was made using a micropipette
tip to help separate the cell sheet from the wall of the
culturing well. Gentle squeezing of culture fluid against
the confined cell sheet using the micropipette tip was
also helpful to aid its detachment from the thermo-
responsive surface. Standard MTT assays were used to
assess HCM cell viability using glass coverslips, tissue
culture plastic wells and poly-L-lysine coated surfaces as
controls.
Statistical analysis
Results are presented as mean ± standard error of the
mean (SEM). Statistical analyses were performed using
the one-way ANOVA test with significance being
assumed for p < 0.05.
Results
Morphological changes of HUMSCs under designed
cardiomyocyte culturing condition induction
We first attempted cardiomyogenic differentiation of
HUMSCs by culturing these cells with different condi-
tioned mediums. HUMSCs, after 5-8 passages, were
seeded onto poly-Llysine coated coverslips in 24-well
plates at the density of 1 × 103 cells/cm2 in DMEM+10%
FBS and grown to adherence. They were then sub-cul-
tured in either CMCM alone or CMCM plus 1 μM S1P;
or DMEM+10%FBS+1 μM S1P. Medium was changed
every three days. The morphological changes of HUMSCs
during cardiomyocyte induction were monitored. Figure 1
shows phase contrast photographs from HUMSCs cells at
the start and after being subject to the conditioned cultur-
ing for 1, 5 and 10 days with different conditioned med-
iums. HUMSCs showed a fibroblast-like morphology
before conditioned culturing (Figure 1A-C), and this phe-
notype was retained through repeated subcultures under
non-stimulating conditions. After induction with condi-
tioned culturing (Figure 1D-K), the cells began to change
their morphology with time. In cells treated with CMCM
or CMCM+S1P, HUMSCs displayed a cardiomyocyte-like
morphology such as myotube-like shape between 5-7 days
after induced culturing. At around 10 days, the
cells became elongated and lined up in CMCM and
CMCM+S1P groups, the differentiated myotubes showed
a number of branches, but the cell group under DMEM
aligned randomly.
Immunocytochemical analysis and patch clamping
confirmed cardiomyogenic differentiation and maturation
Cardiomyogenic differentiation and functional maturation
were then determined by immunocytochemical analysis of
the expression of cardiomyocyte markers and patch
clamping recording of the action potential and voltage
gated membrane currents. Immunostaining with specific
antibodies revealed that cardiomyocyte markers including
myosin heavy chain (MHC) and sarcomeric a-actinin
were strongly expressed in differentiated myocardiomyo-
cytes in CMCM and CMCM+S1P groups. Figure 2A-C,
G-I represents the fluorescent immunostaining of a-
actinin of cells from three groups, while, J-L shows the
fluorescent immunostaining of MHC of cells from these
groups after 5 and 10 days’ culturing. Cells from CMCM
and CMCM+S1P groups show strong expression of both
a-actinin and MHC proteins, but not those cells from
DMEM+S1P group. Figure 3 shows the time dependent
expression and the percentage of cells expressing a-actinin
and sarcomeric a/b myosin cardiac heavy chain after
CMCM or CMCM+S1P treatment. A significant increase
in expression of both markers after 5 days culturing was
observed in both groups.
Figure 4 shows representative examples of action poten-
tial and voltage dependent currents recorded from myo-
cytes of CMCM+S1P group. A rapid upstroke, with lack
of plateau phase action potential (Figure 4A), was recorded
from cells in CMCM+S1P group. Such features were not
observed from the cells in CMCM group. Furthermore, a
voltage dependent inward current (Figure 4B) and a vol-
tage dependent outward current (transient outward like
current) (Figure 4C) can be recorded from the cells that
displayed such action potentials.
Formation and visualization of cell sheets
To explore the therapeutic potential, we then developed
engineered cell sheets from a polymer coated cell cultur-
ing substrate. The thermo-responsive films were coated
onto glass coverslips, which were then placed into the
wells of 24-well plates after thermal annealing, cleaning
and sterilization. Cell culturing was undertaken using
surfaces coated with 1 and 2 mg/ml solution and parallel
studies using bare tissue culture plastic surfaces (TPCS),
glass coverslips (G), coverslips adsorbed with polylysine
(G+L), G+L surface adsorbed with CM medium protein
(G+L+CM).
Cell adhesion was assessed by washing the loosely
attached cells through rinsing with buffer after 24 hr
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culturing. The percentages of cells attached to thermo-
responsive surfaces with and without poly-L-lysine
adsorption were between 80 and 83%; those on the bare
TPCS was just about 80% and those on the bare glass
substrate were between 78 and 80%. Cell morphological
observations indicated that after 2 days of culturing,
there were little visual differences between cells grown
on different surfaces. However, on G+L+CM surface, cell
numbers appeared to be greater. GFP transfection
showed no visible effects arising from surface coating on
the shape or morphology of the cells. Hoechst 33258, a
specific DNA dye that binds the A-T bonds, could reveal
nuclear fragments indicating apoptosis. Under a fluores-
cence microscope, live cells show smooth, weak but visi-
ble light; dead cells do not show colour, but when cells
enter apoptosis,, the cell nuclei and cytoplasm show
Figure 1 UC-MSC cells showed a fibroblast-like morphology before conditioned culturing (AC); the induced cells change their
morphology with time. In cells treated with CMCM or CMCM+S1P, HUMSCs displayed a cardiomyocyte-like morphology such as myotube-like
shape between 5-7 days (D, E, G, H); At around 10 days, the cells became elongated and lined up in CMCM and CMCM+S1P groups (J, K), and
the alignment of the cells appeared in an ordered perpendicular terrace-pattern, like intercalated disc in CMCM+S1P groups. (K). But the cells
had no similar change in S1P+DMEM groups (F, I), and the alignment looked random. (L)
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stains, usually in the form of small lumps and an abnor-
mal nuclear shape. If there are 3 or more fragments or
lumps, the cell is regarded as undergoing apoptosis. No
indication of cell apoptosis was noticed from the PNI-
PAAm coated surfaces. These analyses thus concluded
that the thermo-responsive coated film surfaces did not
cause any adverse effects on cell viability and phenotype.
Cell sheets or films can be separated from the cultur-
ing surface by cooling down to the ambient tempera-
ture, placing the plates in a 4°C fridge for 2-3 minutes
or adding cold cell culture medium to speed up. Films
came off from 10 to 30 minutes upon cooling. Free cell
films could be cut and transported to different surfaces.
A few examples of detached or partially detached cell
films are shown in Figure 5.
Discussion
A number of studies have shown that HUMSCs are able
to differentiate towards multiple lineages under in vitro
conditions including adipocytes, osteoblasts, chondro-
cytes, skeletal myocytes, cardiomyocytes, neurons, and
endothelial cells[1-3]. Given these characteristics,
particularly the plasticity and developmental flexibility,
UC stromal cells are now considered an alternative
source of stem cells and deserve to be examined in
long-term clinical trials, to enable the potential use of
HUMSCs for cell based therapies and tissue engineering
for heart diseases. Differentiating HUMSCs into cardio-
myocytes was less examined and the functional charac-
teristics of HUMSCs differentiated cardiomyocytes have
not been reported so far.
In the present study, we demonstrated that cardiomyo-
cytes can be induced from HUMSCs by designed condi-
tional culturing alone or with conditional culturing
combined with S1P. As demonstrated in Figure 1, after
induction with conditioned culturing, the cells began to
change their morphology with time. In cells treated with
CMCM or CMCM+S1P, HUMSCs displayed a cardio-
myocyte-like morphology such as myotube-like shape
between 5-7 days after induction of culturing. At around
10 days, the cells became elongated and lined up in
CMCM and CMCM+S1P groups. In the S1P+CMCM
group, the alignment of cells appeared in an ordered per-
pendicular pattern, like intercalated disc. Our results
Figure 2 Immunostaining of anti-a-actinin and anti-a MHC in cells at different time points of culturing. A strong expression of both a-actinin
and MHC proteins (A, B, D, E, G, H, J, K) was observed in CMCM and CMCM+S1P groups, but not in cells from the DMEM+S1P group(C, F, I, L).
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indicate that conditioned culturing is the basis for cardio-
myocyte induction of HUMSCs. However, S1P potenti-
ates the differentiation, but alone cannot lead to
cardiomyocyte induction of HUMSCs. Such findings pro-
vide a potential role for S1P in causing cardiomyocyte
induction of HUMSCs under in vivo conditions and
should be an exciting direction to explore in the future.
As demonstrated in Figure 2, Immunostaining with
specific antibodies revealed that cardiomyocyte markers
including myosin heavy chain (MHC) and sarcomeric a-
actinin were strongly expressed in differentiated myo-
cytes in CMCM and CMCM+S1P groups. While both
CMCM and CMCM+S1P groups develop cardiomyocyte-
like cells, identified morphologically and molecularly,
only cells from CMCM+S1P group show electrophysiolo-
gical characteristics of cardiomyocytes with an atrial type
of AP and major voltage gated inward and outward cur-
rents. This suggests that S1P triggers differentiation of
HUMSCs into cardiomyocytes and maturation of
HUMSCs derived cardiomyocytes.
Admittedly, the detailed mechanism(s) of above effects
of S1P on differentiation of and maturation of HUMSCs
derived cardiomyocytes requires further investigation.
S1P is a bioactive Lysophospholipid and signals both
extracellularly, through EDG (Endothelial Differentiation
Gene) receptors (called S1P receptors) coupled to three
heterotrimeric G proteins, Gi, G12/13, and Gq, and intra-
cellularly by undefined mechanisms. S1P has been
known to implicate in a diverse range of biological pro-
cesses, including cell growth, differentiation, migration
and apoptosis in many different cell types. A number of
recent studies provided several lines of evidence to indi-
cate that S1P signals involved in biology of MSCs. Avery
et al demonstrated that S1P plays an important role in
survival and proliferation of hESCs, and found that the
key signaling pathways and downstream targets of S1P
were investigated in a representative cell line hESCs-
Shef 4[4]. A significant rise in ERK1/2 activation with
S1P treatment was witnessed in hESCs maintained on
Figure 3 Histograms showing the percentage of human
umbilical mesenchymal cells expressing a-actin (A) and
sarcomeric a/b myosin cardiac heavy chain (B) after CMCM or
CMCM+S1P treatment. The results are expressed as mean ± SE of
ten randomly selected microscopic fields each from two different
experiments. At least 200 cells were counted in each experiment. A
statistical difference at *P < 0.05 compared with DMEM-only group
and 1 day; *P < 0.05 compared with 5 days. B statistical difference
at *P < 0.05 compared with DMEM-only group and 1 day; *P < 0.05
compared with 5 days.
Figure 4 Representative recordings of action potential (A) and
whole cell voltage gated inward (B) and outward currents (C)
by whole cell patch clamping in myocytes of CMCM+S1P
group. The currents were recorded during 200 ms step
depolarization pulses from a holding potential of -50 mV to a range
of potential between -40 mV and +50 mV.
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murine embryonic fibroblasts (MEFs) exhibiting signifi-
cantly higher levels of active ERK1/2 than those grown
on Matrigel. S1P regulated apoptosis through several
BCL-2 family members, including BAX and BID, with
increased expression of cell cycle progression genes
associated with proliferation of hESC cultures. He et al
[10] recently further investigated the role of S1P in the
growth and multipotency maintenance of human bone
marrow and adipose tissue-derived MSCs. They showed
that S1P induces growth, and in combination with
reduced serum, or with the growth factors FGF and pla-
telet-derived growth factor-AB, S1P has an enhancing
effect on growth. The results demonstrated that S1P is
able to induce proliferation while maintaining the multi-
potency of different human stem cells. Our investigation
indicates that S1P promotes differentiation of HUMSCs
towards cardiomyocytes and functionally maturation of
hUC-MSCs derived cardiomyocytes, such role could be
through S1P receptors coupled to heterotrimeric G pro-
teins and intracellularly by undefined mechanisms.
Myocardial tissue engineering has now emerged as a
promising treatment for heart diseases such as severe
heart failure. As a new transplantation therapy, “cell
sheet engineering” has been developed over the past
decade. Several types of myocardial tissues have been
successfully engineered by seeding cells into poly (glyco-
lic acid), gelatin, alginate or collagen scaffolds[11]. For
examples, Shimizu and coworkers showed that poly-sur-
gerical approach based cell sheet integration appears
feasible for fabricating viable, thick heart tissues with
appropriate vascular network formation and without
mass transport limitations[11]. Wang and coworkers
also have injected MSCs sheet fragments with ECM into
myocardial infarction area to improve the efficacy of
therapeutic cells[12]. Several previous reports have uti-
lized the live growth of a temperature-responsive
Figure 5 Human cardiac myocyte cell film (left) or differentiated HUMSCs (right) in CMCM+S1P group detachment under cooling at
the ambient temperature of 20°C. Top panel shows the local detachment, middle panel shows a large cell sheet peered off and the bottom
panel shows a large pile of cell sheets.
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polymer, poly(N-isopropylacrylamide) (PIPAAm) from
its monomer under electron beam irradiation (e.g., 0.25
MGy electron beam dose) to form temperature-respon-
sive culture surface. In the present study, we developed
a new approach to form PIPAAm based temperature-
responsive culture surfaces. Instead of undertaking live
surface polymerization, our approach involved the easy
first step of coating an already made N-isopropyl acryla-
mide containing copolymer and the second step of
annealing to induce cross-linking within the film and
with the glass substrate for film stability. Subsequent
cell culturing experiments have successfully produced
both neonatal cardiac myocyte and cardiomyocytes
sheets from differentiated human umbilical cord
mesenchymal stem cells. We assessed viability of the
cells of sheets at room temperature. No indication of
cell apoptosis was noticed from the PNIPAAm coated
surfaces. These analyses thus concluded that the
thermo-responsive coated film surfaces did not cause
any adverse effects on cell viability and phenotype.
Further experiment on the survival and characteristic
structures of the cardiomyocyte sheets in vivo is
required. The new engineered cell sheets offers potential
for clinically applicable myocardial tissues and should
promote cardiac tissue engineering research exploiting
the tissue fabrication utilizing ready-made cell sheets.
Conclusions
In the present study, We demonstrated that S1P play a
key role for differentiation of HUMSCs towards func-
tional cardiomyocytes under t cardiac myocytes condi-
tioned medium conditions. Utilizing the technology of
HUMSCs cell sheets, we might find a way for treating
myocardial diseases. However, although functional cardi-
omyocytes have been obtained from HUMSCs in this
study, significant challenges remain in optimizing these
cell preparations for experimental and potential clinical
applications. The heterogeneity of cell types produced in
differentiation protocols can be great even if one suc-
ceeds in isolating cardiomyocytes. For example, using a
mixed population of cardiomyocytes in attempts at left
ventricular repair raises concerns for proarrhythmia
effects. Likewise, a preparation including undifferentiated
cells could lead to tumorigenesis. Thus, approaches to
produce homogenous or well characterized cell prepara-
tions remain a great need.
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